International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14543429
Original Research Article
The Effect of Docosahexaenoic Acid (DHA) Administration on Tumor Necrosis Factor Alpha (TNFα) Levels in Underweight Pregnant Women
Published
Feb. 21, 2024
Abstract

Background: Fulfillment of nutritional needs in pregnant women greatly affects the nutritional status of the fetus in the womb and will determine the growth and development of the baby, especially during the growth period (golden age). In the mother's womb, brain cells undergo various stages of development, namely from proliferation, migration, synaptogenesis to apoptosis. Adequate nutrition is the main and most important factor that plays a role in determining the success of body and brain growth in the fetus. The purpose of this study was to determine the effect of DHA intake on TNFa levels in underweight pregnant women. Methods: The research approach used was cross-sectional and interviews were conducted directly with 21 pregnant women patients in Made Suarabaya District. Results: The average levels of TNFa in underweight pregnant women before and after DHA administration were as follows: 163,746±66,591 and 133,339±39,159 respectively. Conclusions: There is a significant positive effect of providing DHA intake to underweight pregnant women.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2319 Views
163 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved